10-Q

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended JUNE 30, 2013

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                         to                                         

Commission file number 0-11668

INRAD OPTICS, INC.

(Exact name of registrant as specified in its charter)

New Jersey	22-2003247
(State or other jurisdiction of incorporation	(I.R.S. Employer
or organization)	Identification Number)

181 Legrand Avenue, Northvale, NJ  07647

(Address of principal executive offices)

(Zip Code)

(201) 767-1910

(Registrant’s telephone number, including area code)

(Former name, former address and formal fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x   No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x   No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer, accelerated filer and smaller reporting company” in Rule 12b-2 of the exchange Act. (Check one):

Large accelerated filer  ¨ Accelerated filer  ¨ Non-accelerated filer  ¨ Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes ¨   No x

The number of shares of the registrant’s common stock outstanding, $0.01 par value, as of August 14, 2013 was 12,046,003

INRAD OPTICS, INC AND SUBSIDIARIES

INDEX

Part I.	CONDENSED FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements:
	Condensed consolidated balance sheets as of June 30, 2013 (unaudited) and December 31, 2012	2
	Condensed consolidated statements of operations for the three and six months ended June 30, 2013 and 2012 (unaudited)	3
	Condensed consolidated statements of cash flows for the six months ended June 30, 2013 and 2012 (unaudited)	4
	Notes to condensed consolidated financial statements (unaudited)	5
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	10
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	15
Item 4.	Controls and Procedures	15
Part II.	OTHER INFORMATION
Item 1.	Legal Proceedings	16
Item 1A.	Risk Factors	16
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3.	Defaults upon Senior Securities	16
Item 4.	Mine Safety Disclosures	16
Item 5.	Other Information	16
Item 6.	Exhibits	16
Signatures		17

1

INRAD OPTICS, INC AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30,			December 31,
	2013			2012
	(Unaudited)			(Audited)
Assets
Current assets:
Cash and cash equivalents	$	2,465,145		$	3,089,013
Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2013 and 2012)		1,372,270			1,557,930
Inventories, net		3,396,253			3,596,646
Other current assets		111,945			158,742
Total current assets		7,345,613			8,402,331
Plant and equipment:
Plant and equipment,  at cost		16,124,802			15,446,826
Less: Accumulated depreciation and amortization		(14,133,460	)		(14,182,712	)
Total plant and equipment		1,991,342			1,264,114
Precious Metals		474,960			474,960
Goodwill		311,572			311,572
Intangible Assets, net		398,042			437,324
Other Assets		34,838			534,838
Total Assets	$	10,556,367		$	11,425,139
Liabilities and Shareholders’ Equity
Current Liabilities:
Current portion of other long term notes	$	150,200		$	150,200
Accounts payable and accrued liabilities		787,526			813,705
Customer advances		184,739			297,251
Total current liabilities		1,122,465			1,261,156
Related Party Convertible Notes Payable		2,500,000			2,500,000
Other Long Term Notes, net of current portion		794,966			869,135
Total liabilities		4,417,431			4,630,291
Commitments
Shareholders’ Equity:
Common stock: $.01 par value; 60,000,000 authorized shares; 12,050,603 shares issued at June 30, 2013 and 11,881,724 issued at December 31, 2012		120,508			118,819
Capital in excess of par value		18,236,035			18,076,518
Accumulated deficit		(12,202,657	)		(11,385,539	)
		6,153,886			6,809,798
Less - Common stock in treasury, at cost (4,600 shares)		(14,950	)		(14,950	)
Total shareholders’ equity		6,138,936			6,794,848
Total Liabilities and Shareholders’ Equity	$	10,556,367		$	11,425,139

See Notes to Condensed Consolidated Financial Statements (Unaudited)

2

INRAD OPTICS, INC AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Total revenue	$	2,694,598		$	2,880,448		$	5,771,724		$	5,721,129
Cost and expenses:
Cost of goods sold		2,386,866			2,312,614			4,764,894			4,413,339
Selling, general and administrative expenses		909,664			864,804			1,763,472			1,719,093
		3,296,530			3,177,418			6,528,366			6,132,432
Loss from operations		(601,932	)		(296,970	)		(756,642	)		(411,303	)
Other expense:
Interest expense—net		(45,832	)		(36,113	)		(91,476	)		(70,739	)
Gain on sale of plant and equipment		—			—			31,000			—
		(45,832	)		(36,113	)		(60,476	)		(70,739	)
Net loss before income taxes		(647,764	)		(333,083	)		(817,118	)		(482,042	)
Income tax (provision) benefit		—			—			—			—
Net loss	$	(647,764	)	$	(333,083	)	$	(817,118	)	$	(482,042	)
Net loss per common share—basic and diluted	$	(0.05	)	$	(0.03	)	$	(0.07	)	$	(0.04	)
Weighted average shares outstanding—basic and diluted		12,046,003			11,875,874			11,926,328			11,786,207

See Notes to Condensed Consolidated Financial Statements (Unaudited)

3

INRAD OPTICS, INC AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended June 30,
	2013			2012
Cash flows from operating activities:
Net (loss)	$	(817,118	)	$	(482,042	)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Depreciation and amortization		259,094			319,576
401K common stock contribution		80,922			151,775
(Gain) on sale of plant and equipment		(31,000	)		—
Stock based compensation		80,284			106,646
Changes in operating assets and liabilities:
Accounts receivable		185,660			233,291
Inventories, net		200,393			(413,289	)
Other current assets		46,797			64,540
Accounts payable and accrued liabilities		(26,180	)		(30,973	)
Customer advances		(112,512	)		(45,803	)
Total adjustments and changes		683,458			385,763
Net cash (used in) operating activities		(133,660	)		(96,279	)
Cash flows from investing activities:
Capital expenditures		(447,039	)		(180,832	)
Proceeds from sale of plant and equipment		31,000			—
Net cash (used in) investing activities		(416,039	)		(180,832	)
Cash flows from financing activities:
Proceeds from exercise of stock options		—			5,349
Principal payments on notes payable-other		(74,169	)		(4,844	)
Net cash (used in) provided by financing activities		(74,169	)		505
Net (decrease) in cash and cash equivalents		(623,868	)		(276,606	)
Cash and cash equivalents at beginning of period		3,089,013			3,400,205
Cash and cash equivalents at end of period	$	2,465,145		$	3,123,599
Supplemental Disclosure of Cash Flow Information:
Interest paid	$	59,000		$	82,000
Income taxes paid	$	2,000		$	5,000

See Notes to Condensed Consolidated Financial Statements (Unaudited)

4

INRAD OPTICS, INC AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Inrad Optics, Inc. and its subsidiaries (collectively, the “Company”).  All significant intercompany balances and transactions have been eliminated.

The condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year.  For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued.

Management Estimates

These unaudited condensed consolidated financial statements and related disclosures have been prepared in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate.  As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions.  Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

Inventories

Inventories are stated at the lower of cost (first-in-first-out basis) or market. The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow-moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

Inventories are comprised of the following and are shown net of inventory reserves, in thousands:

	June 30, 2013		December 31, 2012
	(Unaudited)
Raw materials	$	1,163	$	1,267
Work in process, including manufactured parts and components		1,123		1,291
Finished goods		1,110		1,039
	$	3,396	$	3,597

5

Income Taxes

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

For the three and six months ended June 30, 2013 and 2012, the Company did not record a current provision for either state or federal income tax due to the losses incurred for both income tax and financial reporting purposes or the availability of net operating loss carry-forwards to offset against federal and state income tax.

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Company over the three-year period ended December 31, 2012 as well as the six months ended June 30, 2013. Such objective evidence limits the ability to consider other subjective evidence such as our projections for future growth.

On the basis of this evaluation, as of June 30, 2013, the Company’s management concluded that it is more likely than not that the Company will not be able to realize any portion of the benefit on the net deferred tax balance of $3,445,000 and therefore the Company continues to maintain a valuation allowance for the full amount of the net deferred tax balance.

When sufficient positive evidence exists, the Company’s income tax expense will be charged with the increase or decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

Net (Loss) Income per Common Share

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.

For the three and six months ended June 30, 2013, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 970,211 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

For the three and six months ended June 30, 2012, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 942,823 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

Stock-Based Compensation

Stock-based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

6

Recently Adopted Accounting Standards

In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU 2013-11 clarifies the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 is effective for interim and annual reporting periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Management does not expect the adoption of ASU 2013-11 to have a material impact on the Company’s financial position, results of operations or cash flows.

NOTE 2- EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION

a) Stock Option Expense

The Company's results of operations for the three months ended June 30, 2013 and 2012 include stock-based compensation expense for stock option grants totaling $38,930 and $45,749, respectively. Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $20,314 ($24,821 for 2012), and selling, general and administrative expenses in the amount of $18,616 ($20,928 for 2012).

The Company's results of operations for the six months ended June 30, 2013 and 2012 include stock-based compensation expense for stock option grants totaling $77,860 and $104,222, respectively. Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $40,628 ($50,697 for 2012), and selling, general and administrative expenses in the amount of $37,232 ($53,525 for 2012).

As of June 30, 2013 and 2012, there were $148,232 and $278,006 of unrecognized compensation cost, net of estimated forfeitures, related to non-vested stock options, which are expected to be recognized over a weighted average period of approximately 1.4 years and 2.2 years, respectively.

There were 80,000 stock options granted during the six months ended June 30, 2013. There were no stock options granted during the six months ended June 30, 2012. The following range of weighted-average assumptions were used to determine the fair value of stock option grants during the six months ended June 30, 2013:

	Six Months Ended
	June 30,
	2013			2012
Expected Dividend yield		—	%		—	%
Expected Volatility		98.1 - 110	%		—	%
Risk-free interest rate		1.9 - 2.1	%		—	%
Expected term		8 - 10 years			—

7

b) Stock Option Activity

The following table represents stock options granted, exercised and forfeited during the six month period ended June 30, 2013:

Stock Options	Number of Options			Weighted Average  Exercise  Price per Option		Weighted Average  Remaining  Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2013		961,823		$	1.00		6.7	$	—
Granted		80,000			.32
Exercised		—			—
Expired/Forfeited		(76,602	)		.67
Outstanding at June 30, 2013		965,221		$	.97		6.4	$	—
Exercisable at June 30, 2013		709,357		$	1.06		5.7	$	—

The following table represents non-vested stock options granted, vested and forfeited for the six months ended June 30, 2013.

	Options			Weighted-Average Grant-Date Fair Value
Non-vested  - January 1, 2013		298,678		$	0.82
Granted		80,000		$	0.28
Vested		(95,112	)	$	0.85
Forfeited		(27,702	)	$	0.86
Non-vested – June 30, 2013		255,864		$	0.63

The total fair value of options vested during the six months ended June 30, 2013 and 2012 was $81,133 and $111,662, respectively.

c) Restricted Stock Unit Awards

There were no grants of restricted stock units granted under the 2010 Equity Compensation Program during the six months ended June 30, 2013 and 2012.

Restricted stock units granted usually vest over a three year period at the rate of one-third per year, contingent on continued employment or service during the vesting period.

The Company's results of operations for the three months ended June 30, 2013 and 2012 include stock-based compensation expense for restricted stock unit grants totaling $1,212 and $1,212, respectively, and such amounts have been included in the accompanying Consolidated Statements of Operations within selling, general and administrative expenses.

The Company's results of operations for the six months ended June 30, 2013 and 2012 include stock-based compensation expense for restricted stock unit grants totaling $2,424 and $2,424, respectively, and such amounts have been included in the accompanying Consolidated Statements of Operations within selling, general and administrative expenses.

8

A summary of the Company’s non-vested restricted stock units at June 30, 2013 is presented below:

	Restricted Stock Units			Weighted-Average Grant-Date Fair Value
Non-vested - January 1, 2013		10,000		$	0.97
Granted		—			—
Vested		(5,000	)	$	0.97
Forfeited		—			—
Non-vested – June 30, 2013		5,000		$	0.97

NOTE 3- STOCKHOLDERS’ EQUITY

For the six months ended June 30, 2013, the Company issued 5,000 common shares on vesting of restricted stock awards. In April 2013, the Company issued an additional 163,879 common shares to the Inrad Optics 401k plan as a match to employee contributions for 2012.

NOTE 4 – OTHER LONG TERM NOTES

On July 26, 2012, the Company entered into a term loan agreement in the amount of $750,000 with Valley National Bank, Wayne, NJ. The loan is payable in equal monthly installments over five years beginning in August 2012 and bears an interest rate of 4.35% annually. The loan is secured with a security interest in new equipment. In 2012, the Company made a down-payment of $500,000 on the equipment and included the payment in Other Assets at December 31, 2012. In March 2013, the Company made an installment payment in the amount of $242,500. During the second quarter of 2013, the installation of the equipment was completed and the final installment payment was made. The cost of the equipment including the down-payments and the associated installation costs were capitalized in the second quarter of 2013.

The Company also has a note payable to the U.S. Small Business Administration which bears interest at the rate of 4.0% and is due in 2032.

Other Long Term Notes consist of the following:

	June 30,			December 31,
	2013			2012
	(in thousands)
Term Note Payable, payable in equal monthly installments of $13,953 and bearing an interest rate of 4.35% and expiring in July 2017	$	625		$	694
U.S. Small Business Administration term note payable in equal monthly installments of $1,922 and bearing an interest rate of 4.0% and expiring in April 2032.	$	320		$	325
		945			1,019
Less current portion		(150	)		(150	)
Long-term debt, excluding current portion	$	795		$	869

9

NOTE 5 – WORKFORCE REDUCTION

In the first quarter of 2013, the Company instituted a plan to reduce its combined headcount by approximately 11%, in order to reduce costs and align its workforce with current business requirements while ensuring the Company would continue to meet its customers’ needs. The reductions affected both the Company’s Northvale, NJ and the Sarasota, FL operations. Annualized savings from the reductions are expected to be approximately $700,000. Severance and other separation costs of $112,000 and $29,000 were expensed in the first quarter and second quarters and offset payroll savings of approximately $45,000 and $175,000 respectively. Accrued severance payments were $39,000 and $71,000 in the first and second quarters of 2013, and additional payments of $31,000 are expected in the third quarter of 2013.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Caution Regarding Forward Looking Statements

This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws. The Company wishes to insure that any forward-looking statements are accompanied by meaningful cautionary statements in order to comply with the terms of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. The events described in the forward-looking statements contained in this Quarterly Report may not occur. Generally, these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of the Company’s plans or strategies, projected or anticipated benefits of acquisitions made by the Company, projections involving anticipated revenues, earnings, or other aspects of the Company’s operating results. The words “may”, “will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”, “estimate”, and “continue”, and their opposites and similar expressions are intended to identify forward-looking statements. The Company cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks, and other influences, many of which are beyond the Company’s control, that may influence the accuracy of the statements and the projections upon which the statements are based. Factors which may affect the Company’s results include, but are not limited to, the risks and uncertainties discussed in Items 1A, 7 and 7A of the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission on April 1, 2013. Any one or more of these uncertainties, risks, and other influences could materially affect the Company’s results of operations and whether forward-looking statements made by the Company ultimately prove to be accurate. Readers are further cautioned that the Company’s financial results can vary from quarter to quarter, and the financial results for any period may not necessarily be indicative of future results. The foregoing is not intended to be an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by the Company. The Company’s actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether from new information, future events, or otherwise.

Critical Accounting Policies and Estimates

Our significant accounting policies are described in Note 1 of the accompanying consolidated financial statements and further discussed in our annual financial statements included in our annual report on Form 10-K for the year ended December 31, 2012. In preparing our condensed consolidated financial statements, we made estimates and judgments that affect the results of our operations and the value of assets and liabilities we report. These include estimates used in evaluating goodwill and intangibles for impairment such as market multiples used in determining the fair value of reporting units, discount rates applicable in determining net present values of future cash flows, projections of future sales, earnings and cash flow and capital expenditures. It also includes estimates about the amount and timing of future taxable income in determining the Company’s valuation allowance for deferred income tax assets. Our actual results may differ from these estimates under different assumptions or conditions.

10

For additional information regarding our critical accounting policies and estimates, see the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report filed with the Securities and Exchange Commission on Form 10-K for the year ended December 31, 2012.

Results of Operations

Inrad Optics, Inc.’s business falls into two main categories: Optical Components and Laser System Devices and Instrumentation.

The Optical Components category is focused on custom optics manufacturing. The Company specializes in high-end precision components. It develops, manufactures and delivers precision custom optics and thin film optical coating services through its Custom Optics and Metal Optics operations. Glass, metal, and crystal substrates are processed using modern manufacturing equipment, complex processes and techniques to manufacture components, deposit optical thin films, and assemble sub-components used in advanced photonic systems. The majority of custom optical components and optical coating services supplied are used in inspection, process control systems, defense and aerospace electro-optical systems, laser system applications, industrial scanners, and medical system applications.

The Laser System Devices and Instrumentation category includes the growth and fabrication of crystalline materials with electro-optic (EO) and non-linear optical properties for use in both standard and custom products. This category also includes the manufactured crystal based devices and associated instrumentation. The majority of crystals, crystal components and laser devices manufactured are used in laser systems, defense EO systems, medical lasers and R&D applications by engineers within corporations, universities and national laboratories.

The Company operates manufacturing facilities in New Jersey and Florida.

Revenue

Sales for the three months ended June 30, 2013 were $2,695,000, a decrease of 6.4%, compared to $2,880,000 for the three months ended June 30,2012. Sales for the six months ended June 30, 2013 were $5,771,000, a slight increase from $5,721,000 for the six months ended June 30, 2012. Sales in the Optical Components category increased 4.2% for the six months ended June 30, 2013 compared with the prior year. Sales of Laser Systems Devices and Instrumentation decreased 5.2% over the same period.

Shipments to customers in the universities & national laboratories market increased. This was offset by decreased shipments in the process control & metrology markets, the laser systems market and the defense/aerospace market which was spread across most of the Company’s existing customers in those markets with the exception of a few customers that recorded sales increases.

Sales to major customers defined as those who represent more than 10% of period sales, were down as a percentage of total sales in the first six months of 2013 compared with the same period in 2012. This was due to lower sales to one large laser systems market customer that was partially offset by an increase in sales to one large defense market customer compared to the same period in the prior year.

The Company’s top five customers represented 34.3% of total sales in the six month period ended June 30, 2013, down from 43.4% in the same period in 2012.

Orders during the first six months of 2013 compared to 2012, decreased to $4.8 million compared to $6.3 million last year

Order backlog was $4.9 million at June 30, 2013, down compared to $5.9 million at December 31, 2012 and $5.6 million at June 30, 2012.

11

Cost of Goods Sold

Cost of goods sold was $2,387,000 for the three months ended June 30, 2013 compared to $2,313,000 in the same quarter in 2012, an increase of $74,000 or 3.2%. For the six months ended June 30, 2013, cost of goods sold increased by $352,000 or 8.0% to $4,765,000 compared to $4,413,000 in the same period in 2012.

As a percentage of sales, cost of goods sold increased to 88.6% compared to 80.3% in 2012 for the three months ended June 30, 2013. For the six months ended June 30, 2013, cost of goods sold as a percentage of sales was 82.6% compared to 77.1% in the same period in 2012.

Manufacturing wages and salaries, including related fringe benefits, increased by 1.5% and 7.2%, respectively, during the three and six months ended June 30, 2013, compared to same period last year, as a result of the shift in our historical customer mix discussed above.

The impact of the Company’s work force reduction in March and April, 2013 had a net positive impact over the six months ended June 30, 2013. Severance costs included in cost of goods sold were $29,000 and $141,000 in the three and six months ended June 30, 2013. These costs were offset by associated payroll savings which amounted to approximately $175,000 and $220,000 in the respective periods.

Material costs decreased 28.7% and 11.7% during the three and six months ended June 30, 2013, respectively, compared with the same periods in 2012, mainly due to the change in sales mix, discussed above.

Gross margin decreased for the three and six month period ended June 30, 2013 as a result of the factors discussed above. Gross margin in the second quarter of 2013 was $308,000 or 11.4% versus $567,000 or 19.7% in the same period in 2012. For the six months ended June 30, 2013, gross margin decreased to $1,007,000 or 17.4% compared with $1,308,000 or 22.9% in the comparable period in 2012.

Selling, General and Administrative Expenses

Selling, general and administrative expenses (“SG&A” expenses) in the three and six months ended June 30, 2013 amounted to $910,000 or 33.8% of sales and $1,763,000 or 30.5% of sales, respectively, compared to $865,000 or 30.0% of sales and $1,719,000 or 30.0% of sales, respectively, for the same periods in 2012. For the three and six months ended June 30, 2013, SG&A expenses included approximately $29,000 and $75,000 in severance costs related to the workforce reduction discussed in Note 5 to the Condensed Consolidated Financial Statements. Associated payroll savings from the workforce reduction was $69,000 and $85,000 for the three and six months ended June 30, 2013.

(Loss) from Operations

The Company had an operating loss of $602,000 in the three months ended June 30, 2013 compared with an operating loss of $297,000 in the three months ended June 30, 2012. For the six months ended June 30, 2013, the Company had an operating loss of $757,000 compared with an operating loss of $411,000 in the same period last year. The operating losses in 2013 and 2012 primarily reflect the impact of the level of sales on the Company’s relatively fixed cost structure.

Other Income and Expense

For the three months ended June 30, 2013, net interest expense was $46,000, up from $36,000 in the same period in 2012. For the six months ended June 30, 2013, net interest expense was $91,000, up from $71,000 in the same period in 2012.

Interest expense for the three months ended June 30, 2013 increased to $48,000 compared to $41,000 in the same period in 2012. Interest expenses for the six months ended June 30, 2013 increased to $96,000 compared to $82,000 in the same period in 2012. The increase in both periods is mainly attributable to the addition of a term note with Valley National Bank in the third quarter of 2012.

Interest income during the three and six months ended June 30, 2013 was $2,000 and $5,000, respectively, compared with $5,000 and $11,000, respectively, in the comparable periods in 2012, and results from lower average cash balances in interest bearing accounts over the comparable periods.

12

In the first quarter of 2013, the Company sold surplus machinery and recorded a gain of $31,000.

Income Taxes

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

For the three and six months ended June 30, 2013 and 2012, the Company did not record a current provision for either state or federal income tax due to the losses incurred for both income tax and financial reporting purposes or the availability of net operating loss carry-forwards to offset against federal and state income tax.

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Company over the three-year period ended December 31, 2012 as well as the six months ended June 30, 2013. Such objective evidence limits the ability to consider other subjective evidence such as our projections for future growth.

On the basis of this evaluation, as of June 30, 2013, the Company’s management concluded that it is more likely than not that the Company will not be able to realize any portion of the benefit on the net deferred tax balance of $3,445,000. As a result, the Company maintains a valuation allowance for the full amount of the net deferred tax balance.

When sufficient positive evidence exists, the Company’s income tax expense will be charged with the increase or decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

Net (Loss)

For the three and six months ended June 30, 2013, the Company had a net loss of $648,000 and $817,000, respectively, compared to a net loss of $333,000 and $482,000, respectively, for the same periods in 2012.

Liquidity and Capital Resources

The Company’s primary source of liquidity is cash and cash equivalents and on-going collection of accounts receivable. The Company’s major use of cash in recent years has been for the payment of accrued and current interest on convertible debt, the servicing of long term debt and for capital expenditures.

As of June 30, 2013 and December 31, 2012, the Company had cash and cash equivalents of $2,465,000 and $3,089,000, respectively.

On July 26, 2012, the Company entered into a term loan agreement with Valley National Bank, Wayne, NJ, in the amount of $750,000. The loan is secured with a security interest in new equipment acquired by the Company in the amount of $825,000 which will enhance the Company’s thin film coating capabilities. The loan is repayable in equal monthly installments over five years beginning in August 2012 and bears an interest rate of 4.35% annually. In 2012, the Company made a down-payment of $500,000 on the equipment and included the payment in Other Assets at December 31, 2012. In March 2013, the Company made an installment payment in the amount of $242,500. During the second quarter of 2013, the installation of the equipment was completed and the final installment payment of $82,500 was made. The cost of the equipment including installment payments and associated installation costs were capitalized in the second quarter of 2013 in the amount of $897,000 with an additional $70,000 capitalized for leasehold improvements associated with the equipment.

13

We believe that existing cash resources held by the Company and anticipated to be generated from future operating activities are sufficient to meet working capital requirements, anticipated capital expenditures, debt servicing payments and other contractual obligations over the next 12 months.

On July 31, 2012, the maturity dates of a $1,500,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”) and a $1,000,000 Subordinated Convertible Promissory Note to an affiliate of Clarex were each extended to April 1, 2015 from April 1, 2013. The notes bear interest at 6%. Interest accrues yearly and is payable on maturity. Unpaid interest, along with principal, may be converted into securities of the Company as follows: the notes are convertible in the aggregate into 1,500,000 units and 1,000,000 units, respectively, with each unit consisting of one share of common stock and one warrant. Each warrant allows the holder to acquire 0.75 shares of common stock at a price of $1.35 per share and expire on April 1, 2018. The Company paid current interest of $37,500 in each quarter during the six months ended June 30, 2013 and 2012. The Company expects to make interest payments of $37,500 in the remaining quarters of 2013 and in each quarter through the maturity date of the notes to satisfy the amounts of interest accruing in each quarter.

The following table summarizes net cash (used in) operating, investing and financing activities for the six months ended June 30, 2013 and 2012:

	Six Months Ended
	June 30,
	2013			2012
	(In thousands)
Net cash (used in) operating activities	$	(134	)	$	(96	)
Net cash (used in) investing activities		(416	)		(181	)
Net cash (used in) financing activities		(74	)		-
Net (decrease) in cash and cash equivalents	$	(624	)	$	(277	)

Net cash used in operating activities was $134,000 for the six months ended June 30, 2013 compared to $96,000 in the same period last year. The decrease in net cash from operating activities in the first six months of 2013 compared to 2012 resulted primarily from the higher net loss generated in the current period.

Accounts receivables decreased by $186,000 at June 30, 2013 compared to a decrease of $233,000 the same period last year. The decrease was mainly the result of the timing of shipments and the collection of balances during the six months ended June 30, 2013 compared to the prior year.

Inventory balances decreased by $200,000 in the six months ended June 30, 2013 compared to an increase of $413,000 in the six months ended June 30, 2012 which was the result of planned reductions in 2013 primarily attributable to the reduction in orders placed in the current year.

Accounts payable and accrued liabilities decreased by $26,000 in the six months ended June 30, 2013 compared to a decrease of $31,000 in 2012 principally due to the timing of payments as the Company continues to optimize its use of cash.

Non-cash items consist of depreciation and amortization, stock based compensation expense and the Company’s annual 401K matching stock contribution for the six months ended June 30, 2013 and 2012.

Net cash used in investing activities was $416,000 during the six months ended June 30, 2013 versus $181,000 last year. Capital expenditures for the six months ended June 30, 2013 and 2012 were $447,000 and $181,000, respectively. The expenditures in 2013 were primarily for the balance owed on new equipment purchased to enhance the Company’s thin film coating capabilities and the associated installation costs at the Northvale facility. The expenditures in 2012 were primarily incurred to refurbish operating facilities in New Jersey and Florida and to purchase manufacturing equipment. The Company also sold surplus machinery during the six months ended June 30, 2013 and received net proceeds of $31,000.

14

Net cash used in financing activities during the six months ended June 30, 2013 totaled $74,000 compared to net cash provided of $500 in the comparable period in 2012. The increase in cash used in 2013 is mainly attributable to the principal payments made on the term loan with Valley National Bank that the Company entered into in the third quarter of 2012 to finance the acquisition of new equipment. The net cash provided in 2012 consisted primarily of proceeds from theexercise of stock options for $5,500, offset by principal payments on long term notes of $5,000.

Overall, the Company had a net decrease in cash and cash equivalents of $624,000 in the six months ended June 30, 2013 compared with a decrease of $277,000 in the corresponding period last year.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is a smaller reporting company and not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES

a. Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of June 30, 2013 (the “Evaluation Date”), have concluded that as of the Evaluation Date, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports we file or submit under the Exchange Act (1) is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (2) is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.

b. Changes in Internal Controls over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

15

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Not applicable

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UNDER SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

11. An exhibit showing the computation of per-share earnings is omitted because the computation can be clearly determined from the material contained in this Quarterly Report on Form 10-Q.

31.1 Certificate of the Registrant’s Chief Executive Officer, Amy Eskilson, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2 Certificate of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 Certificate of the Registrant’s Chief Executive Officer, Amy Eskilson, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2 Certificate of the Registrant’s Chief Financial Officer, William J. Foote, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101 The following financial information from Inrad Optics, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2013 formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements.*

__________

* Users of this interactive data file are advised pursuant to Rule 406T of Regulations S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these Sections.

16

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Inrad Optics, Inc.
By:	/s/ Amy Eskilson
	Amy Eskilson
	President and Chief Executive Officer
By:	/s/  William J. Foote
	William J. Foote
	Chief Financial Officer,
	Secretary and Treasurer

Date: August 14, 2013

17

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Amy Eskilson certify that:

1. I have reviewed the quarterly report on Form 10-Q of Inrad Optics, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d -15(f)) for the registrants and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function(s):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  August 14, 2013	/s/ Amy Eskilson
	President and Chief Executive Officer

A signed original of this written statement required by Section 302 has been provided to Inrad Optics, Inc. and will be retained by Inrad Optics, Inc. and furnished to the Securities Exchange Commission or its staff upon request.

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, William J. Foote certify that:

1. I have reviewed the quarterly report on Form 10-Q of Inrad Optics, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d -15(f)) for the registrants and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function(s):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  August 14, 2013	/s/ William J. Foote
	Chief Financial Officer,
	Secretary and Treasurer

A signed original of this written statement required by Section 302 has been provided to Inrad Optics, Inc. and will be retained by Inrad Optics, Inc. and furnished to the Securities Exchange Commission or its staff upon request.

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inrad Optics, Inc. on Form 10-Q for the period ended June 30, 2013 filed with the Securities and Exchange Commission (the “Report”), I, Amy Eskilson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Dated: August 14, 2013

/s/ Amy Eskilson

President and Chief Executive Officer

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and has not been filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to Inrad Optics, Inc. and will be retained by Inrad Optics, Inc. and furnished to the Securities Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inrad Optics, Inc. on Form 10-Q for the period ended June 30, 2013 filed with the Securities and Exchange Commission (the “Report”), I, William J. Foote, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

Dated: August 14, 2013

/s/ William J. Foote

Chief Financial Officer,

Secretary and Treasurer

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and has not been filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to Inrad Optics, Inc. and will be retained by Inrad Optics, Inc. and furnished to the Securities Exchange Commission or its staff upon request.

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Details)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Expected Dividend yield	0.00%	0.00%
Expected Volatility		0.00%
Risk-free interest rate		0.00%
Expected term		0 years
Minimum [Member]
Expected Volatility	98.10%
Risk-free interest rate	1.90%
Expected term	8 years
Maximum [Member]
Expected Volatility	110.00%
Risk-free interest rate	2.10%
Expected term	10 years

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Total revenue	$ 2,694,598	$ 2,880,448	$ 5,771,724	$ 5,721,129
Cost and expenses:
Cost of goods sold	2,386,866	2,312,614	4,764,894	4,413,339
Selling, general and administrative expenses	909,664	864,804	1,763,472	1,719,093
Costs and Expenses, Total	3,296,530	3,177,418	6,528,366	6,132,432
Loss from operations	(601,932)	(296,970)	(756,642)	(411,303)
Other expense:
Interest expense-net	(45,832)	(36,113)	(91,476)	(70,739)
Gain on sale of plant and equipment	0	0	31,000	0
Other (expense) income, Total	(45,832)	(36,113)	(60,476)	(70,739)
Net loss before income taxes	(647,764)	(333,083)	(817,118)	(482,042)
Income tax (provision) benefit	0	0	0	0
Net loss	$ (647,764)	$ (333,083)	$ (817,118)	$ (482,042)
Net loss per common share - basic and diluted (in dollars per share)	$ (0.05)	$ (0.03)	$ (0.07)	$ (0.04)
Weighted average shares outstanding - basic and diluted (in shares)	12,046,003	11,875,874	11,926,328	11,786,207

XML

WORKFORCE REDUCTION

6 Months Ended

Jun. 30, 2013

Workforce Reduction [Abstract]

Workforce Reduction Disclosure [Text Block]

NOTE 5 – WORKFORCE REDUCTION

In the first quarter of 2013, the Company instituted a plan to reduce its combined headcount by approximately 11%, in order to reduce costs and align its workforce with current business requirements while ensuring the Company would continue to meet its customers’ needs. The reductions affected both the Company’s Northvale, NJ and the Sarasota, FL operations. Annualized savings from the reductions are expected to be approximately $700,000. Severance and other separation costs of $112,000 and $29,000 were expensed in the first quarter and second quarters and offset payroll savings of approximately $45,000 and $175,000 respectively. Accrued severance payments were $39,000 and $71,000 in the first and second quarters of 2013, and additional payments of $31,000 are expected in the third quarter of 2013.

XML

OTHER LONG TERM NOTES (Details Textual) (USD $)	1 Months Ended	6 Months Ended
	Jul. 26, 2012	Jun. 30, 2013
Term Note Payable [Member]
Debt Instrument, Frequency of Periodic Payment		equal monthly installments
Debt Instrument, Periodic Payment		$ 13,953
Debt Instrument, Interest Rate, Stated Percentage		4.35%
Debt Instrument, Maturity Date		Jul. 31, 2017
Cash Down Payment	500,000
Asset Held As Security Purchase Price Installment Payment		242,500
Debt Instrument, Face Amount	750,000
Long-term Debt, Maturities, Repayment Terms	five years
Debt Instrument, Issuance Date	Aug. 01, 2012
Us Small Business Administration Note Payable [Member]
Debt Instrument, Frequency of Periodic Payment		equal monthly installments
Debt Instrument, Periodic Payment		$ 1,922
Debt Instrument, Interest Rate, Stated Percentage		4.00%
Debt Instrument, Maturity Date		Apr. 30, 2032

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Details 1) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Number of Options, Outstanding at January 1, 2013	961,823
Number of Options, Granted	80,000
Number of Options, Exercised	0
Number of Options, Expired/Forfeited	(76,602)
Number of Options, Outstanding at June 30, 2013	965,221	961,823
Number of Options, Exercisable at June 30, 2013	709,357
Weighted Average Exercise Price per Option, Outstanding at January 1, 2013	$ 1.00
Weighted Average Exercise Price per Option, Granted	$ 0.32
Weighted Average Exercise Price per Option, Exercised	$ 0
Weighted Average Exercise Price per Option, Expired/Forfeited	$ 0.67
Weighted Average Exercise Price per Option, Outstanding at June 30, 2013	$ 0.97	$ 1.00
Weighted Average Exercise Price per Option, Exercisable at June 30, 2013	$ 1.06
Weighted Average Remaining Contractual Term (years), Outstanding	6 years 8 months 12 days	6 years 4 months 24 days
Weighted Average Remaining Contractual Term (years), Exercisable at March 31, 2013	5 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding at January 1, 2013	$ 0
Aggregate Intrinsic Value, Outstanding at June 30, 2013	0	0
Aggregate Intrinsic Value, Exercisable at June 30, 2013	$ 0

XML

WORKFORCE REDUCTION (Details Textual) (USD $)	3 Months Ended
	Jun. 30, 2013	Mar. 31, 2013
Percentage Reduction In Work Force	11.00%
Annualized Savings Due To Reduction In Work Force	$ 700,000
Severance Costs	29,000	112,000
Offset Payroll Savings Amount	175,000	45,000
Severance Costs Payable Quarter One	39,000
Severance Costs Payable Quarter Two	71,000
Severance Costs Payable Quarter Three	$ 31,000

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

NOTE 1 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Inrad Optics, Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated.

The condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued.

Management Estimates

These unaudited condensed consolidated financial statements and related disclosures have been prepared in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

Inventories

Inventories are stated at the lower of cost (first-in-first-out basis) or market. The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow-moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

Inventories are comprised of the following and are shown net of inventory reserves, in thousands:

	June 30,  2013		December 31,  2012
		(Unaudited)
Raw materials	$	1,163	$	1,267
Work in process, including manufactured parts and components		1,123		1,291
Finished goods		1,110		1,039
	$	3,396	$	3,597

Income Taxes

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

For the three and six months ended June 30, 2013 and 2012, the Company did not record a current provision for either state or federal income tax due to the losses incurred for both income tax and financial reporting purposes or the availability of net operating loss carry-forwards to offset against federal and state income tax.

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Company over the three-year period ended December 31, 2012 as well as the six months ended June 30, 2013. Such objective evidence limits the ability to consider other subjective evidence such as our projections for future growth.

On the basis of this evaluation, as of June 30, 2013, the Company’s management concluded that it is more likely than not that the Company will not be able to realize any portion of the benefit on the net deferred tax balance of $3,445,000 and therefore the Company continues to maintain a valuation allowance for the full amount of the net deferred tax balance.

When sufficient positive evidence exists, the Company’s income tax expense will be charged with the increase or decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

Net (Loss) Income per Common Share

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.

For the three and six months ended June 30, 2013, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 970,211 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

For the three and six months ended June 30, 2012, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 942,823 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

Stock-Based Compensation

Stock-based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model.The fair value of restricted stock units granted is based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

Recently Adopted Accounting Standards

In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU 2013-11 clarifies the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 is effective for interim and annual reporting periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Management does not expect the adoption of ASU 2013-11 to have a material impact on the Company’s financial position, results of operations or cash flows.

XML

STOCKHOLDERS' EQUITY

6 Months Ended

Jun. 30, 2013

Stockholders' Equity Note [Abstract]

Stockholders Equity Note Disclosure [Text Block]

NOTE 3- STOCKHOLDERS’ EQUITY

For the six months ended June 30, 2013, the Company issued 5,000 common shares on vesting of restricted stock awards. In April 2013, the Company issued an additional 163,879 common shares to the Inrad Optics 401k plan as a match to employee contributions for 2012.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Inrad Optics, Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated.

The condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued.

Use of Estimates, Policy [Policy Text Block]

Management Estimates

These unaudited condensed consolidated financial statements and related disclosures have been prepared in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

Inventory, Policy [Policy Text Block]

Inventories

Inventories are stated at the lower of cost (first-in-first-out basis) or market. The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow-moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

Inventories are comprised of the following and are shown net of inventory reserves, in thousands:

	June 30,  2013		December 31,  2012
		(Unaudited)
Raw materials	$	1,163	$	1,267
Work in process, including manufactured parts and components		1,123		1,291
Finished goods		1,110		1,039
	$	3,396	$	3,597

Income Tax, Policy [Policy Text Block]

Income Taxes

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

For the three and six months ended June 30, 2013 and 2012, the Company did not record a current provision for either state or federal income tax due to the losses incurred for both income tax and financial reporting purposes or the availability of net operating loss carry-forwards to offset against federal and state income tax.

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income consistent with the plans and estimates that management uses to manage the underlying business. A significant piece of objective negative evidence evaluated was the cumulative loss incurred by the Company over the three-year period ended December 31, 2012 as well as the six months ended June 30, 2013. Such objective evidence limits the ability to consider other subjective evidence such as our projections for future growth.

On the basis of this evaluation, as of June 30, 2013, the Company’s management concluded that it is more likely than not that the Company will not be able to realize any portion of the benefit on the net deferred tax balance of $3,445,000 and therefore the Company continues to maintain a valuation allowance for the full amount of the net deferred tax balance.

When sufficient positive evidence exists, the Company’s income tax expense will be charged with the increase or decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

Earnings Per Share, Policy [Policy Text Block]

Net (Loss) Income per Common Share

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.

For the three and six months ended June 30, 2013, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 970,211 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

For the three and six months ended June 30, 2012, all common stock equivalents were excluded from the computation of diluted net loss per share because their effect is anti-dilutive. This included 942,823 common stock equivalents related to outstanding options and grants, in each respective period. In addition, there were 2,500,000 common shares and 1,875,000 warrants issuable upon conversion of outstanding related party convertible notes in each period which were anti-dilutive.

Compensation Related Costs, Policy [Policy Text Block]

Stock-Based Compensation

Stock-based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model.The fair value of restricted stock units granted is based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Standards

In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ASU 2013-11 clarifies the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 is effective for interim and annual reporting periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Management does not expect the adoption of ASU 2013-11 to have a material impact on the Company’s financial position, results of operations or cash flows.

XML

OTHER LONG TERM NOTES

6 Months Ended

Jun. 30, 2013

Other Liabilities Disclosure [Abstract]

Other Liabilities Disclosure [Text Block]

NOTE 4 – OTHER LONG TERM NOTES

On July 26, 2012, the Company entered into a term loan agreement in the amount of $750,000 with Valley National Bank, Wayne, NJ. The loan is payable in equal monthly installments over five years beginning in August 2012 and bears an interest rate of 4.35% annually. The loan is secured with a security interest in new equipment. In 2012, the Company made a down-payment of $500,000 on the equipment and included the payment in Other Assets at December 31, 2012. In March 2013, the Company made an installment payment in the amount of $242,500. During the second quarter of 2013, the installation of the equipment was completed and the final installment payment was made. The cost of the equipment including the down-payments and the associated installation costs were capitalized in the second quarter of 2013.

The Company also has a note payable to the U.S. Small Business Administration which bears interest at the rate of 4.0% and is due in 2032.

Other Long Term Notes consist of the following:

	June 30,		December 31,
	2013		2012
	(in thousands)
Term Note Payable, payable in equal monthly installments of $13,953 and bearing an interest rate of 4.35% and expiring in July 2017	$	625	$	694
U.S. Small Business Administration term note payable in equal monthly installments of $1,922 and bearing an interest rate of 4.0% and expiring in April 2032.	$	320	$	325
		945		1,019
Less current portion		(150)		(150)
Long-term debt, excluding current portion	$	795	$	869

XML

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Jun. 30, 2013	Dec. 31, 2012
Allowance for doubtful accounts (in dollars)	$ 15,000	$ 15,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	60,000,000	60,000,000
Common stock, shares issued	12,050,603	11,881,724
Treasury stock, shares	4,600	4,600

XML

OTHER LONG TERM NOTES (Tables)

6 Months Ended

Jun. 30, 2013

Other Liabilities Disclosure [Abstract]

Schedule of Debt [Table Text Block]

Other Long Term Notes consist of the following:

	June 30,		December 31,
	2013		2012
	(in thousands)
Term Note Payable, payable in equal monthly installments of $13,953 and bearing an interest rate of 4.35% and expiring in July 2017	$	625	$	694
U.S. Small Business Administration term note payable in equal monthly installments of $1,922 and bearing an interest rate of 4.0% and expiring in April 2032.	$	320	$	325
		945		1,019
Less current portion		(150)		(150)
Long-term debt, excluding current portion	$	795	$	869

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net (loss)	$ (817,118)	$ (482,042)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Depreciation and amortization	259,094	319,576
401K common stock contribution	80,922	151,775
(Gain) on sale of plant and equipment	(31,000)	0
Stock based compensation	80,284	106,646
Changes in operating assets and liabilities:
Accounts receivable	185,660	233,291
Inventories, net	200,393	(413,289)
Other current assets	46,797	64,540
Accounts payable and accrued liabilities	(26,180)	(30,973)
Customer advances	(112,512)	(45,803)
Total adjustments and changes	683,458	385,763
Net cash (used in) operating activities	(133,660)	(96,279)
Cash flows from investing activities:
Capital expenditures	(447,039)	(180,832)
Proceeds from sale of plant and equipment	31,000	0
Net cash (used in) investing activities	(416,039)	(180,832)
Cash flows from financing activities:
Proceeds from exercise of stock options	0	5,349
Principal payments on notes payable-other	(74,169)	(4,844)
Net cash (used in) provided by financing activities	(74,169)	505
Net (decrease) in cash and cash equivalents	(623,868)	(276,606)
Cash and cash equivalents at beginning of period	3,089,013	3,400,205
Cash and cash equivalents at end of period	2,465,145	3,123,599
Supplemental Disclosure of Cash Flow Information:
Interest paid	59,000	82,000
Income taxes paid	$ 2,000	$ 5,000

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2013	Dec. 31, 2012
Assets
Cash and cash equivalents	$ 2,465,145	$ 3,089,013
Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2013 and 2012)	1,372,270	1,557,930
Inventories, net	3,396,253	3,596,646
Other current assets	111,945	158,742
Total current assets	7,345,613	8,402,331
Plant and equipment:
Plant and equipment, at cost	16,124,802	15,446,826
Less: Accumulated depreciation and amortization	(14,133,460)	(14,182,712)
Total plant and equipment	1,991,342	1,264,114
Precious Metals	474,960	474,960
Goodwill	311,572	311,572
Intangible Assets, net	398,042	437,324
Other Assets	34,838	534,838
Total Assets	10,556,367	11,425,139
Liabilities and Shareholders' Equity
Current portion of other long term notes	150,200	150,200
Accounts payable and accrued liabilities	787,526	813,705
Customer advances	184,739	297,251
Total current liabilities	1,122,465	1,261,156
Related Party Convertible Notes Payable	2,500,000	2,500,000
Other Long Term Notes, net of current portion	794,966	869,135
Total liabilities	4,417,431	4,630,291
Commitments
Shareholders' Equity:
Common stock: $.01 par value; 60,000,000 authorized shares; 12,050,603 shares issued at June 30, 2013 and 11,881,724 issued at December 31, 2012	120,508	118,819
Capital in excess of par value	18,236,035	18,076,518
Accumulated deficit	(12,202,657)	(11,385,539)
Stockholders' Equity before Treasury Stock	6,153,886	6,809,798
Less - Common stock in treasury, at cost (4,600 shares)	(14,950)	(14,950)
Total shareholders' equity	6,138,936	6,794,848
Total Liabilities and Shareholders' Equity	$ 10,556,367	$ 11,425,139

XML

OTHER LONG TERM NOTES (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Note Payable	$ 945,000	$ 1,019,000
Less current portion	(150,000)	(150,000)
Long-term debt, excluding current portion	794,966	869,135
Term Note Payable [Member]
Note Payable	625,000	694,000
Us Small Business Administration Note Payable [Member]
Note Payable	$ 320,000	$ 325,000

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following range of weighted-average assumptions were used to determine the fair value of stock option grants during the six months ended June 30, 2013:

	Six Months Ended June 30,
	2013			2012
Expected Dividend yield		—	%		—	%
Expected Volatility		98.1 - 110	%		—	%
Risk-free interest rate		1.9 - 2.1	%		—	%
Expected term		8 - 10 years			—

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table represents stock options granted, exercised and forfeited during the six month period ended June 30, 2013:

Stock Options	Number of  Options		Weighted  Average  Exercise  Price per Option		Weighted  Average  Remaining  Contractual  Term (years)		Aggregate  Intrinsic Value
Outstanding at January 1, 2013		961,823	$	1.00		6.7	$	—
Granted		80,000		.32
Exercised		—		—
Expired/Forfeited		(76,602)		.67
Outstanding at June 30, 2013		965,221	$	.97		6.4	$	—
Exercisable at June 30, 2013		709,357	$	1.06		5.7	$	—

Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested [Table Text Block]

The following table represents non-vested stock options granted, vested and forfeited for the six months ended June 30, 2013.

	Options		Weighted-Average Grant-Date  Fair Value
Non-vested - January 1, 2013		298,678	$	0.82
Granted		80,000	$	0.28
Vested		(95,112)	$	0.85
Forfeited		(27,702)	$	0.86
Non-vested – June 30, 2013		255,864	$	0.63

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of the Company’s non-vested restricted stock units at June 30, 2013 is presented below:

	Restricted Stock Units		Weighted-Average Grant-Date  Fair Value
Non-vested - January 1, 2013		10,000	$	0.97
Granted		—		—
Vested		(5,000)	$	0.97
Forfeited		—		—
Non-vested – June 30, 2013		5,000	$	0.97

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance			$ 3,445,000
Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,500,000	2,500,000	2,500,000	2,500,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,875,000	1,875,000	1,875,000	1,875,000
Common Stock Options And Grants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	970,211	942,823	970,211	942,823

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories are comprised of the following and are shown net of inventory reserves, in thousands:

	June 30,  2013		December 31,  2012
		(Unaudited)
Raw materials	$	1,163	$	1,267
Work in process, including manufactured parts and components		1,123		1,291
Finished goods		1,110		1,039
	$	3,396	$	3,597

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION

6 Months Ended

Jun. 30, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE 2- EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION

a) Stock Option Expense

The Company's results of operations for the three months ended June 30, 2013 and 2012 include stock-based compensation expense for stock option grants totaling $38,930 and $45,749, respectively. Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $20,314 ($24,821 for 2012), and selling, general and administrative expenses in the amount of $18,616 ($20,928 for 2012).

The Company's results of operations for the six months ended June 30, 2013 and 2012 include stock-based compensation expense for stock option grants totaling $77,860 and $104,222, respectively. Such amounts have been included in the accompanying Condensed Consolidated Statements of Operations within cost of goods sold in the amount of $40,628 ($50,697 for 2012), and selling, general and administrative expenses in the amount of $37,232 ($53,525 for 2012).

As of June 30, 2013 and 2012, there were $148,232 and $278,006 of unrecognized compensation cost, net of estimated forfeitures, related to non-vested stock options, which are expected to be recognized over a weighted average period of approximately 1.4 years and 2.2 years, respectively.

There were 80,000 stock options granted during the six months ended June 30, 2013. There were no stock options granted during the six months ended June 30, 2012. The following range of weighted-average assumptions were used to determine the fair value of stock option grants during the six months ended June 30, 2013:

	Six Months Ended June 30,
	2013			2012
Expected Dividend yield		—	%		—	%
Expected Volatility		98.1 - 110	%		—	%
Risk-free interest rate		1.9 - 2.1	%		—	%
Expected term		8 - 10 years			—

b) Stock Option Activity

The following table represents stock options granted, exercised and forfeited during the six month period ended June 30, 2013:

Stock Options	Number of  Options		Weighted  Average  Exercise  Price per Option		Weighted  Average  Remaining  Contractual  Term (years)		Aggregate  Intrinsic Value
Outstanding at January 1, 2013		961,823	$	1.00		6.7	$	—
Granted		80,000		.32
Exercised		—		—
Expired/Forfeited		(76,602)		.67
Outstanding at June 30, 2013		965,221	$	.97		6.4	$	—
Exercisable at June 30, 2013		709,357	$	1.06		5.7	$	—

The following table represents non-vested stock options granted, vested and forfeited for the six months ended June 30, 2013.

	Options		Weighted-Average Grant-Date  Fair Value
Non-vested - January 1, 2013		298,678	$	0.82
Granted		80,000	$	0.28
Vested		(95,112)	$	0.85
Forfeited		(27,702)	$	0.86
Non-vested – June 30, 2013		255,864	$	0.63

The total fair value of options vested during the six months ended June 30, 2013 and 2012 was $81,133 and $111,662, respectively.

c) Restricted Stock Unit Awards

There were no grants of restricted stock units granted under the 2010 Equity Compensation Program during the six months ended June 30, 2013 and 2012.

Restricted stock units granted usually vest over a three year period at the rate of one-third per year, contingent on continued employment or service during the vesting period.

The Company's results of operations for the three months ended June 30, 2013 and 2012 include stock-based compensation expense for restricted stock unit grants totaling $1,212 and $1,212, respectively, and such amounts have been included in the accompanying Consolidated Statements of Operations within selling, general and administrative expenses.

The Company's results of operations for the six months ended June 30, 2013 and 2012 include stock-based compensation expense for restricted stock unit grants totaling $2,424 and $2,424, respectively, and such amounts have been included in the accompanying Consolidated Statements of Operations within selling, general and administrative expenses.

A summary of the Company’s non-vested restricted stock units at June 30, 2013 is presented below:

	Restricted Stock Units		Weighted-Average Grant-Date  Fair Value
Non-vested - January 1, 2013		10,000	$	0.97
Granted		—		—
Vested		(5,000)	$	0.97
Forfeited		—		—
Non-vested – June 30, 2013		5,000	$	0.97

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Details 2) (USD $)	6 Months Ended
	Jun. 30, 2013
Options, Non-vested - January 1, 2013	298,678
Options, Granted	80,000
Options, Vested	(95,112)
Options, Forfeited	(27,702)
Options, Non-vested - June 30, 2013	255,864
Weighted-Average Grant-Date Fair Value, Non-vested at January 1, 2013 (in dollars per share)	$ 0.82
Weighted-Average Grant-Date Fair Value, Granted (in dollars per share)	$ 0.28
Weighted-Average Grant-Date Fair Value, Vested (in dollars per share)	$ 0.85
Weighted-Average Grant-Date Fair Value, Forfeited (in dollars per share)	$ 0.86
Weighted-Average Grant-Date Fair Value, Non-vested at June 30, 2013 (in dollars per share)	$ 0.63

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Raw materials	$ 1,163,000	$ 1,267,000
Work in process, including manufactured parts and components	1,123,000	1,291,000
Finished goods	1,110,000	1,039,000
Inventories, net	$ 3,396,253	$ 3,596,646

XML

STOCKHOLDERS' EQUITY (Details Textual)	6 Months Ended
	Jun. 30, 2013
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period	5,000
Stock Issued During Period, Shares, Employee Benefit Plan	163,879

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Details 3) (USD $)	6 Months Ended
	Jun. 30, 2013
Non-vested Restricted Stock Units, Outstanding January 1, 2013	10,000
Non-vested Restricted Stock Units, Granted	0
Non-vested Restricted Stock Units, Vested	(5,000)
Non-vested Restricted Stock Units, Forfeited	0
Non-vested Restricted Stock Units, Outstanding June 30, 2013	5,000
Weighted Average Grant Date Fair Value, Non-vested Restricted Stock Units, Outstanding January 1, 2013 (in dollars per share)	$ 0.97
Weighted Average Grant Date Fair Value, Non-vested Restricted Stock Units, Granted (in dollars per share)	$ 0
Weighted Average Grant Date Fair Value, Non-vested Restricted Stock Units, Vested (in dollars per share)	$ 0.97
Weighted Average Grant Date Fair Value, Non-vested Restricted Stock Units, Forfeited (in dollars per share)	$ 0
Weighted Average Grant Date Fair Value, Non-vested Restricted Stock Units, Outstanding June 30, 2013 (in dollars per share)	$ 0.97

XML

Document And Entity Information	6 Months Ended
	Jun. 30, 2013	Aug. 14, 2013
Document Information [Line Items]
Entity Registrant Name	Inrad Optics, Inc.
Entity Central Index Key	0000719494
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	INRD
Entity Common Stock, Shares Outstanding		12,046,003
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2013

XML

EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total			80,000
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	$ 38,930	$ 45,749	$ 77,860	$ 104,222
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	148,232	278,006	148,232	278,006
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (in years)			1 year 4 months 24 days	2 years 2 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total			80,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value			81,133	111,662
Employee Stock Option [Member] | Cost of Sales [Member]
Allocated Share-based Compensation Expense	20,314	24,821	40,628	50,697
Employee Stock Option [Member] | Selling General and Administrative Expense [Member]
Allocated Share-based Compensation Expense	18,616	20,928	37,232	53,525
Restricted Stock Units (Rsus) [Member] | Selling General and Administrative Expense [Member]
Allocated Share-based Compensation Expense	$ 1,212	$ 1,212	$ 2,424	$ 2,424